Company Filing History:
Years Active: 2022
Title: Max Medina-Ramirez: Innovator in HIV Research
Introduction
Max Medina-Ramirez is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of HIV research through his innovative work. His expertise and dedication have led to the development of a unique patent that addresses critical aspects of HIV treatment.
Latest Patents
Max holds a patent for "HIV envelope glycoprotein immunogens." This invention relates to an isolated, recombinant, or synthetic polypeptide comprising an Env polypeptide of an HIV virus. The Env polypeptide includes at least the amino acid residues K275, D276, and R278, with the numbering based on the HxB2 reference sequence having the amino acid sequence of SEQ ID NO: 1. This patent represents a significant advancement in the understanding and potential treatment of HIV.
Career Highlights
Max is currently affiliated with the Academisch Medisch Centrum, where he continues to engage in groundbreaking research. His work focuses on developing innovative solutions to combat HIV, showcasing his commitment to improving public health outcomes.
Collaborations
Max collaborates with Rogier Sanders, a fellow researcher in the field. Their partnership enhances the research efforts and contributes to the advancement of knowledge in HIV immunology.
Conclusion
Max Medina-Ramirez is a dedicated inventor whose work in HIV research has the potential to make a lasting impact. His innovative patent and collaboration with esteemed colleagues highlight his commitment to advancing medical science.